Group One Trading’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Group One Trading's CTMX Position: Q3 2026 in Review
Group One Trading opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 11,970 shares worth $32.6K. The stake represents ﹤0.01% of the portfolio and ranks #5552 among its holdings. This is a return to the name: Group One Trading previously reported a position in CTMX as recently as Q1 2026.
Group One Trading first reported a position in CTMX in Q4 2017 and has held it in 19 quarters since. The position peaked at $724K in Q1 2026. 194 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Group One Trading held 11,970 shares of CytomX Therapeutics worth $32.6K as of Q3 2026.
- CytomX Therapeutics was a new Group One Trading position in Q3 2026.
- CytomX Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5552 holding.
- Group One Trading first reported a position in CytomX Therapeutics in Q4 2017 and has held it in 19 quarters since.
- Group One Trading's CytomX Therapeutics position peaked at $724K in Q1 2026.
- 194 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.